Goal Management Training for Adult Survivors of Childhood Leukemia and Non-Hodgkins Lymphoma With Neurocognitive Sequelae

Inclusion Criteria

• •The Norwegian Cancer Registry will identify participants based on the following criteria:
• •Acute Lymphoblastic Leukaemia (ALL), Acute Myelogen Leukemia (AML), non Hodgkins Lymphoma diagnosed between 1980 - 2017
• •Age when diagnosed \<18 år (0-17years)
• •Age at survey 18-40 years
• •Born between 1980 - 2004
• •Minimum five years (≥5) post ALL, AML, NHL diagnosis
• •ALL, AML, NHL treatment at Oslo University Hospital and St. Olavs Hospital
• •Screening/baseline:
• •Written informed consent
• •≥5 years from diagnosis
• •Age 18-40
• •Without cancer recurrence the last five years
• •Understand and speak Norwegian
• •Experiencing executive dysfunction as determined by a semi-structured interview
• •Cognitive capacity to engage with the training, and General Ability Index (GAI) Score ≥70 measured by Wechsler Intelligence Scale for Adults (WAIS-IV)